01833 PA GOODDOCTOR
- 11.140
- -0.080-0.71%
PA GOODDOCTOR News
Ping An Health (01833) was selected as “2024 Forbes China Brand Value Series Selection”
Recently, Forbes China released the results of the “2024 Forbes China Brand Value Series Selection”, and Ping An Health (01833) was selected as the “2024 Forbes China Brand Value Series Selection” — the “Top 50 Best Brands of the Year”.
Changes in Hong Kong stocks | Ping An Health (01833) rose more than 5% in the intraday period to launch Guangzhou Medical Insurance Online Payment and Drug Purchase Service
The Zhitong Finance App learned that Ping An Health (01833) rose more than 5% in the intraday period. As of press release, it had risen 4.09% to HK$10.18, with a turnover of HK$307.35,800. According to the news, Ping An Health announced that after announcing the launch of the online medical insurance drug purchase service in Dongguan at the end of March, online medical insurance payments have now also been implemented in Guangzhou. This time, Guangzhou Medical Insurance also supports co-ordinated accounts and personal accounts to provide users with new payment options, further enhance the convenience of online drug purchases, and reduce the financial burden on citizens. The person in charge of Ping An Health said that in the future, Ping An Health will continue in other cities across the country
Ping An Healthcare and Technology Company Limited's (HKG:1833) 26% Dip Still Leaving Some Shareholders Feeling Restless Over Its P/SRatio
The Ping An Healthcare and Technology Company Limited (HKG:1833) share price has fared very poorly over the last month, falling by a substantial 26%. Instead of being rewarded, shareholders who hav
Public Companies Among Ping An Healthcare and Technology Company Limited's (HKG:1833) Largest Stockholders and Were Hit After Last Week's 15% Price Drop
Key Insights Significant control over Ping An Healthcare and Technology by public companies implies that the general public has more power to influence management and governance-related decisions A
Online medical insurance payments connect the cities of Dongguan and Guangzhou! Ping An Health (01833) Advances Multiple Ways to Innovate Internet Healthcare
Ping An of China (02318)'s high-speed railway connecting healthcare services to the main financial industry is being consolidated at an accelerated pace.
PA GOODDOCTOR: Annual Report 2023
The value of Ping An of China's (02318) 2023 earnings report has been underestimated by the market
Entering a new growth trajectory
Changes in Hong Kong stocks | Dr. Ping An (01833) bucked the market and turned upward, and the front-end back-end strategy progressed smoothly and was well received by many major international companies after the company's performance
The Hang Seng Index plummeted by more than 2% in the intraday period, and Ping An Good Doctor (01833) rebounded and increased by more than 8% after the results. As of press release, it rose 1.22% to HK$13.3, with a turnover of HK$34.831 million.
Analysts Have Been Trimming Their Ping An Healthcare and Technology Company Limited (HKG:1833) Price Target After Its Latest Report
Shareholders of Ping An Healthcare and Technology Company Limited (HKG:1833) will be pleased this week, given that the stock price is up 13% to HK$13.14 following its latest full-year results. I
Ping An Good Doctor's front-end and back-end strategy progressed smoothly, and Daimo raised the target price to HK$21
Morgan Stanley published a research report on Safe Doctor (01833) on March 20, 2024. The bank's analysts said that considering the company's adjusted net loss was further reduced, and the front-end+back-end 'expansion progressed smoothly,” the target price set for Ping An Good Doctor was HK$21, which meant that the stock had room to rise by 71%. The report shows that in the second half of 2023, Ping An Good Doctor's revenue increased 10.3% year-on-year. By business segment, the medical service business grew 0.8% year on year in the second half of 2023, and the health service business grew 18 year on year.
Dahua Jixian: Strategic business is expected to achieve double-digit growth and maintain Ping An Good Doctor (01833) “buy” rating
Dahua Jixian released a research report, maintaining the “Buy” rating of Ping An Good Doctor (01833) and assigning a target price of HK$15.
Ping An Good Doctor (01833)'s front-end and back-end strategy progressed smoothly, and Daimo raised the target price to HK$21
Morgan Stanley set a target price of HK$21 for Ping An Good Doctor, which means that the stock has room to rise 71%.
UBS: Strategy 2.0 has achieved results and a target price of HK$20 for Safe Doctor (01833)
The Zhitong Finance App learned that UBS (UBS), a major international bank, recently released a research report setting a target price of HK$20 for Ping An Good Doctor (01833), stressing that the company's 2023 performance was in line with expectations, that the steady progress of Strategy 2.0 reduced losses rapidly, and that steady growth in the F-side business was compounded by rapid B-side business growth. UBS commented in the research report that in 2023, the company achieved revenue of 4.7 billion yuan, in line with market expectations; net loss in 2023 and net loss adjusted under non-IFRS standards were 335 million yuan and 315 million yuan respectively, compared to the same period last year
Changes in Hong Kong stocks | Ping An Health (01833) rose more than 8% AI technology operation empowers doctors to improve efficiency and increase the company's gross margin of medical and health services
Ping An Health (01833) rose more than 8% and rose 8.29% at press time to HK$13.32, with a turnover of HK$35.44 million.
Understand the 2023 Ping An Health Annual Report report card in one picture
On March 19, 2024, Ping An Healthcare Technology Co., Ltd. (stock abbreviation “Ping An Good Doctor”, 1833.HK) announced its 2023 annual results report. Let me take you to understand the specific results in a picture.
The managed medical model has been firmly implemented, Ping An Health's gross margin increased steadily throughout 2023, and profits are expected to be realized at an accelerated pace
SHANGHAI, March 20, 2024/PRNewswire/ -- On March 19, 2024, Ping An Healthcare Technology Co., Ltd. (stock abbreviation “Ping An Good Doctor”, 1833.HK, hereinafter referred to as “Ping An Health” or “Company”) announced its 2023 annual results report. With core competitive advantages such as rich payer resources for medical and health services such as insurance, financial clients, enterprises, etc., an extensive network of service providers, a perfect service standard system, and strong Ping An ecological resources, Ping An Health deepens the implementation of managed medical strategies and deeply cultivated the two core hubs of “family doctors” and “pension managers”
[Hong Kong Stock Connect] Dr. Ping An (01833)'s loss rose 49.28% to RMB 323 million without dividend payment last year
Jin Wu Financial News | Dr. Ping An (01833) announced that for the year ended December 31, 2023, losses attributable to company owners recorded a loss of 323 million yuan (RMB, same below), a year-on-year decrease of 49.28%. The basic loss per share was 0.3 yuan, with no dividend. During the period, revenue was recorded at $4.674 billion, a year-on-year decrease of 24.68%. The company recorded F-side strategic business revenue (that is, F-end medical and health service revenue, same later) of 2.205 billion yuan, an increase of 14.8% year-on-year, and 4.5% month-on-month increase in the second half of the year; recorded B-side strategic business revenue (referring to enterprise health business, B-side medical and health services)
Building two core hubs, “Family Doctor” and “Elderly Care Manager”, Ping An Health is expected to accelerate profits
On March 19, 2024, Ping An Healthcare Technology Co., Ltd. (stock abbreviation “Ping An Good Doctor”, 1833.HK, hereinafter referred to as “Ping An Health” or “Company”) announced its 2023 annual results report. During the reporting period, Ping An Health continued to deepen the implementation of managed medical care strategies and deeply cultivate the construction of two core hubs: “family doctor” and “elderly care manager”. The company recorded annual revenue of 4.67 billion yuan, and net loss narrowed sharply by 47.6% year-on-year to 330 million yuan. At the same time, the business structure was continuously optimized, driving the company's gross margin to rise 5.4 percentage points to 32.3% year on year, and profits are expected to increase
Ping An Healthcare & Technology: Net Loss Narrowed Due to Realignment of Businesses, Increasing Rev From Business With High Profitability >1833.HK
Ping An Healthcare & Technology: Net Loss Narrowed Due to Realignment of Businesses, Increasing Rev From Business With High Profitability >1833.HK
Ping An Healthcare & Technology 2023 Rev CNY4.67B Vs. CNY6.21B >1833.HK
Ping An Healthcare & Technology 2023 Rev CNY4.67B Vs. CNY6.21B >1833.HK
Analysis
Price Target
No Data
